Metabolic Disorders Therapeutics Market: Overview and Emerging Trends

Global Metabolic Disorders Therapeutics Market Size, Share & Trends Analysis Report By Disorder Type (Diabetes, Obesity, Hyperthyroidism, Hypercholesterolemia, Phenylketonuria (PKU), Lysosomal Storage Diseases (e.g., Gaucher disease, Fabry disease), Other Metabolic Disorders By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) – Forecast (2024-2032)
The Metabolic Disorders Therapeutics Market was USD 62.14 Billion in 2023 and is expected to grow USD 67.79 Billion in 2024. It is expected to continue growing at a CAGR of 9.1%, reaching USD 136.07 Billion by 2032.
List of Companies Profiled
- Novo Nordisk A/S
- Sanofi S.A.
- Eli Lilly and Company
- Pfizer Inc.
- Merck & Co., Inc.
- AstraZeneca
- Amgen Inc.
- Takeda Pharmaceutical Company Limited
- Biogen Inc.
- Johnson & Johnson
Report Scope and Segmentations
Study Period | 2024-32 |
Base Year | 2023 |
Estimated Forecast Year | 2024-32 |
Growth Rate | CAGR of 9.1% from 2024 to 2032 |
Segmentation | By Disorder Type, By Drug Class, By Route of Administration, By Treatment Type, By End User, By Distribution Channel, By Region |
Unit | USD Billion |
By Disorder Type |
|
By Drug Class |
|
By Route of Administration |
|
By Treatment Type |
|
By End User |
|
By Distribution Channel |
|
By Region |
|
About US:
IMIR® Market Research Pvt Ltd.
Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.
IMIR has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Follow Us: LinkedIn
Mr. Smit Patel
Phone: +1 (814) 487 8486
Email: smit@intellectualmarketinsights.com
Corporate Sales: sales@intellectualmarketinsights.com